Neonatology Flashcards

1
Q

Adrenaline

A

class: catecholamine

mechanism: beta>alpha

  • beta 1/beta 2 effects prominent at lower doses

effect: ionotrophy/chronotrophy, peropheral vasoconstriction (beta 1)/dilation (beta 2)

use: cardiac arrest, low output state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aneurysm Vein of Galen

A

definition: most common AVM in infants and increases in size with age

clinical: cardiac failure (80% CO), hydrocephaly, cranial bruit, SAH

diagnosis: ultrasound

management: surgery but >50% can’t be corrected

prognosis: early death if not corrected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antenatal steroids

A

Weeks 24-34 if probable delivery within 1 week

Benefits:

  • decreased RDS/NEC/IVH/sepsis/DD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anaemia of prematurity

A

Pathophysiology:

  • EPO made fetal liver/kidney and increases gestation
  • preterm have lower EPO/Hct at birth
  • EPO decreases at birth
  • RBC 45-50d in ELBW (term 60-80d)

Clinical:

  • normocytic, normochromic anaemia with low retics
  • onset 3-12 weeks, asymptomatic till 70
  • symptoms: tachycardia, FTT, hypoxia, apnoea

Management:

  • limit blood samplings
  • Iron supplementation 1st year 2-4mg/kg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Apnoea of prematurity

A

definition: cessation of resp airflow

incidence:

  • 33-35wks: 50%

pathogenesis:

  • physiological immaturity of central/peripheral chemoreceptors, neuronal signals
  • +/- impaired resp drive or poor airway patency
  • usually mixed obstructive/central apnoea

clinical: increased frequency wks 2-3, resolves wk 37

management: monitoring, NIPPV, methylxanthines (caffeine/theophylline) stimulate resp neural ouput

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bell staging for NEC

A

Stage 1 (suspected) with feed intolerance, AXR distension

  • 1A grossly bloody stools
  • 1B grossly bloody stools

Stage 2 (proven) with pneumatosis intestinalis and portal venous gas

  • 2A mildly ill
  • 2B moderately ill (met acidosis, thrombocytopaenia)

Stage 3 (advanced) AXR dilation/pneumatoses/ascites and systemic effect

  • 3A bowel intact
  • 3B bowel perforation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Benefits Breastmilk

A

GI: growth, motility, hormones, GF, anti-inflammatory agents, NEC prophylaxis, beneficial microbes, increased gastric emptying/lactase, decreased mucosal permeability

Antimicrobial: lactoferrin, lysozyme, IgA secreted into BM (10% milk protein), WBCs (90% neutrophils/macrophages), lacrobacillus/bifidobacteria

Decreased infections: lower hospitilisations, less severe illness, less gastro/resp/OM/UTI/sepsis

Long term: decreased obesity, DM1, IBD, allergies, cancer, adult CVD, better neurological outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bilateral Vocal Cord Paralysis

A

incidence: 3rd most common congenital laryngeal anomaly producing stridor

associations: myelomeningocele, Arnold-Chiari malformation, hydrocephalus

clinical: high-pitched inspiratory stridor

diagnosis: flexible laryngoscopy

treatment: may require temporary trache

prognosis: resolve by 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Birth fractures

A

nasal septum

clavicular: most common
humerus: 0.2/1000, most common long bone
femur: 0.13/1000
skull: linear and depressed, usually assisted delivery
dislocations: very uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Birth nerve injuries

A

brachial plexus: most common 0.2%

facial nerve: forceps/compression against sacrum. affects manibular branch with drooping nasolabial fold. resolves

phrenic nerve: assoc brachial plxus injury. resp involvement day 1.

laryngeal nerve: hoarse voice/stridor.

spinal cord: very rare. upper cervical more common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BPD/CLD

A

Disease of bronchioles and acini in premature infants

Definition: reliance on oxygen/resp support >28days or >36/40

Incidence: 97% in BW

Risks: prematurity (23-32wks), IUGR (

Pathophysiology: airway injury/inflammation, parenchymal fibrosis, oxygen toxicity, disruption of lung development due to surfactant

Classification at 36 weeks:

Mild: RA

Moderate: FiO2

Severe: FiO2>30% and/or PPV

Clinical: may have wheeze

CXR: diffuse haziness (atelectasis, inflammation, oedema), cystic changes

Management: high CO2, wean oxygen, nutrition, diuretics, Vit A, low dose dexamethasone

Prognosis: most improve 2-4 months and wean off oxygen, PFTs may not improve (decreased FEV1/FVC/TLC), hyperresponsiveness with asthma like symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes Hydrops Fetalis

A

Aneuploidy most common 24 weeks

  1. Genetic: 10%, aneuploidy, congenital MD, skeletal dysplasia, single gene defect
  2. Metabolic storage disease: 1-15%, auto recessive
  3. Cardiovascular abnormalities: 40%, structural, arrhythmias, vasc abnormalities
  4. Thoracic abnormalities: obstruct venous return
  5. Pleural effusions
  6. Anaemia: 10-27%, alpha thal
  7. Infections: 8%, Parvo B19, TORCH
  8. GI malformations
  9. GU malformations
  10. TTTS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Choanal atresia

A

incidence: 1/5000 (2/3 unilateral)

definition: obliteration of posterior nasal aperture

clinical: cyanosis, worse with feeding, relieved by crying

diagnosis: probe with catheter

treatment: early surgery

associations: CHARGE, T21, Treacher-Collins, Apert’s, Crouzon’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Closure of sutures

A

Posterior fontanelle: 2 months

Anterior fontanelle: 2 years

Coronal: 3 months

Lamboid: 1 year

Metopic: 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complications BPD

A
  • Pulmonary/systemic HTN
  • L ventricular hypertrophy
  • Tracheobronchomalacia, tracheal/bronchial stenosis, glottic/subglottic damage
  • sleep hypoxemia
  • Resp infections
  • Neurodevelopmental problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications PN

A

Line: sepsis, extravasation, phlebitis

Metabolic: hyperglycaemia, nephrocalcinosis, hyperlipidaemia, hyperammonaemia, bone disease

Liver: 25% neonates >2wks, deranged LFTs (esp GGT, conj bilirubin), cholestasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Congenital CMV

A

MOST COMMON perinatal/congenital infection

organism: herpesvirus DNA virus

epidemiology: 50% pregnant women seropositive, 10% reactivate during pregnancy

tranmission: low transmission via secretions

incubation: 3-12 weeks

pregnancy: infection 1st trimester highest risk, 3rd trimester highest rate

clinical:

10% symptoms at birth:

  • growth: microcephaly, SGA
  • haem:anaemia, thrombocytopaenia, petechiae, purpura
  • GI: hepatosplenomegally, jaundice, elevated LFTs
  • neuro: seizures, brain periventricular calcifications/cysts/ventriculomegaly
  • eye: chorioretinitis, optic atrophy, central vision loss

90% asymptomatic: then develop unilateral hearing loss, behavioural issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Congenital Laryngeal Cleft

A

incidence: 1: 10,000

definition: cleft to the posterior laryngotracheal wall

  • gap between trachea and oesophagus

clinical: cough, cyanosis, pulmonary infections

treatment: thickened feeds, surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Congenital Lobar Emphysema

A

incidence: 1/25,000

pathophysiology: progressive massive uniform dilation of a lobe due to obstruction of developing airway

  • deficiency of cartilage in defect

clinical: 1/3 present at birth, all by 1 yr with increased WOB due to compression of lung

  • increased risk infection
  • decreased AE over lesion
  • 15% assoc CHD

CXR:

  • hyperinflated area extending across mediastinum
  • mediastinal shift and contralateral lung partial collapse
  • LUL (50%)>RUL>RML>lower lobes (10%)

treatment: early resection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Congenital Myotonic Dystrophy

A

associated: decreased fetal movements, polyhydramnios

clinical: hypotonia, respiratory distress, facial weakness, muscle atrophy

diagnosis: triplet repeat studies (CTG repeat), mildly elevated CK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Congenital rubella

A

transmission: highest risk infection in 1st trimester and after 36 weeks

risk of defects: highest in first 16 weeks

  • <8wks: 100%
  • 8-12wks: 50%
  • 12-20wks: 20%
  • >20wks: 1%

congenital symptoms:

prenatal: abortion, stillbirth

post natal (infection

  • IUGR, cataracts/retinopathy, microcephaly, cardiac (PDA/PPS), sensorineural deafness, blueberry muffin, haem (LN/hepatosplenomegally, thrombocytopaenia, anaemia), long bone radiolucencies, pneumonitis, renal tract abnormalities

post natal (infection>12 wks gestation)

  • retinopathy and deafness only

diagnosis: maternal seroconversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Congenital syphilis

A

organism: treponema pallidum

transfer: transplacental, extrauterine

congenital: chorioretinitis, glaucoma, periositis, hepatosplenomegally

clinical: symptoms 1-2 weeks

  • mucosal/cutaneous disease (peeling or skin, rash palms/soles)
  • pneumonitis/myocarditis
  • LN
  • bone

diagnosis: PRP, VDRL, THTA

treatment: IV benzyl penicillin 10 days

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Congenital toxoplasmosis

A

source: cats

incidence: 0.2/1000

transmission: 1st trimester 15%, 2nd 30%, 3rd 60%

clinical:

  • more congenital abnormalities if in 1st trimester
  • most asymptomatic at birth but 85% SNHL/DD
  • classic tetrad: chorioretinitis, hydrocephalus, IC calcifications
  • also: hydrops anaemia, blueberry muffin spots, purpura, seizures, hepatomegally

diagnosis: paired maternal/infant serology

  • then CSF, CT, opthalmology, audiology

treatment:

  • during pregnancy: spiramycin
  • amnio +ve: pyrimethamine + sulphadiazine
  • neonatal: pyrimethamine for 1 year + folinic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Congenital VZV

A

pregnant women exposure >5 mins evaluated

  • no action if previous infection/positive serology
  • ZIG within 96 hours after exposure if non immune
  • aciclovir

fetal VZV

  • in 10-15% of maternal chickenpox

fetal VZV syndrome

  • microcephally, low IQ, seizures, skin scarring, ipsilateral limb hypoplasia

congenital diagnosis

  • amniocentesis confirms infection
  • ultrasound confirms symptomatic infection

perinatal VZV

  • risk 7 days before and 2 days after delivery and requires ZIG
  • outside this period only high risk infants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Contraindication to breastfeeding

A

HIV positive

HCV positive with cracked nipples

Human T cell lymphotropic virus +ve

Herpetic breast lesions

Varicella 5 days prior

Active TB (until >2wks with treatment)

Cocaine, cannabis, alcohol use

Galactosemia

Drugs: Chemo, Immunosuppresants, Lithium, Clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cranial injuries

A

caput succedaneum: oedema, diffuse swelling to skin/subcutaneous tissue

cephalohaematoma (1-2%): subperiosteal btw periosteum/bone. onset in hours lasting 2 weeks. does not cross sutures.

subgaleal: subaponeurotic btw apneurosis/periosteum due to shearing emissary veins. fluctuant/boggy. potential massive blood loss. crosses suture lines. can cause consumptive coagulopathy.

extradural: between skull/dura. classically middle cerebral artery.

subdural: between dura/arachnoid. rare but most common ICH.

subarachnoid (subependymal): between arachnoid/pia mater. communicates CSF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Craniosynostosis

A

definition: premature closure of the cranial sutures (single 85%, multi 15%)

- primary: premature closure of one of more sutures

- secondary: from failure of brain growth/expansion

incidence: 1/2000 (10-20% assoc syndrome)

complications: raised ICP, inhibition brain growth, impaired cognition/growth/feeding/weight/vision/hearing/speech

management: plastic surgery with 3D CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Developmental Dysplasia Hip

A

incidence: 1:1000

2 forms: typical or teratologic (cause)

RFs: female (80%), family hx (12-30%), tight uterine space, breech, 1st born, other moulding issues

associations: congenital torticollis, metatarsus adductus, clubfoot

pathology:

  • significant lig laxity (estrogen, relaxin) allowing spontaneous dislocation
  • secondary flattening acetabulum, muscle contractures and joint capsule tightening
  • L to R 3:1

clinical: barlow/ortolani, galeazzi sign

  • hip abduction <75 degrees, adduction > 30 degrees

imaging: US: high false positives week 0-4

  • alpha angle: line from ileum to roof acetabulum

treatment:

  • <6m Pavlik harness (95% success dysplasia, 80% dislocation)
  • 6m-2yrs: closed reduction with hip spica
  • >2yrs or failed rx: open reduction

complications: iatrogenic avascular necrosis femoral epiphysis, pressure ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Diaphragmatic Eventration

A

cause: part of diaphragm replaced fibroelastic tissue but diaphragm intact
etiology: congenital/acquired (phrenic nerve injury)

CXR: elevated diaphragm

Management: oxygen, NG feeds, surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Diaphragmatic hernia

A

aetiology: traumatic or congenital 1/10,000

pathogenesis: abdominal viscera to herniate into chest causing lung hypoplasia and pulmonary artery hyperplasia

location: 80-90% left side, Bochdalek 90%, Morgagni 2-6%

outcome: lung hypoplasia, pulmonary HTN

clinical: barrel chest, scaphoid abdomen, absent breath sounds

treatment: surgery, ventilation, NGT

outcome: resp distress birth-weeks, 67% survival

long term outcome: PPHN, GOR, FTT, neurodev delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Dobutamine

A

class: synthetic catecholamine (same basic structure as dopamine)

effect: predominantly beta 1 and small amount beta 2 with selective alpha 1

use: low CO state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Dopamine

A

class: endogenous catecholamine

mechanism: DA> beta> alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Encephalopathy

A

Incidence: 9:1000

Definition: pH34wks, no other explanation

+ AGPAR 0-3 at 5 mins, multi system involvement

Aetiology: 80% acute, 3% prenatal, 3% non HIE

  • mild: hyperalert, hyperexcitable, normal tone
  • moderate: hypotonia, decreased movements, sometimes seizures
  • severe: stuporous, flaccid, absent reflexes, seizures

Prognosis: poor if MRI findings, increased lactate, EEG findings

  • mild: likely normal
  • moderate: 20-35% sequelae
  • severe: 75% die in neonatal periods

Investigations

MRI: poor outcome bilateral thalamic/internal capsule/brainstem lesions

EEG: burst suppression, isoelectricity, low voltage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Bronchopulmonary sequestration

A

incidence: 1/10,000

definition: non-functioning mass lung tissues that lacks normal communication with the tracheobronchial tree

Pathophysiology:

  • 95% left lung
  • located in or outside normal lung with own viscera
  • receives blood supply from systemic circulation

clinical: respiratory distress, pneumonia

  • many patients asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Feeding cleft palate/micrognathia

A

cleft palate: sucking problems

micrognathia: airway problem
- cleft: poor suction, usually require bottle or NG top up
- micrognathia: tongue to far back to attach to nipple, may need nasopharyngeal tube to keep airway patent and tongue forward in feed

treatment:

  • SP within 24 hours of birth
  • squeezable bottle
  • feed in semi-upright position to minimise nasal regurg milk
  • burp regularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

GBS sepsis

A

organism: strep agglacticae gram +ve cocci

epidemiology: 30% women colonised

transmission: 50% transmission w/o prophylaxis

  • increased PROM, chorio, prematurity, heavy titre, intrapartum fever, previous GBS disease
  • most significant is SPROM

risk factors GBS positive: DM, teenager, tampons,

early onset disease:

  • sepsis (50%), pneumonia (30%), meningitis (15%)
  • mortality: 4.7%

later onset (>7 days) and no relationship to maternal status:

  • bacteraemia (50%), meningitis (30%), focal (20%)
  • 2.8% mortality

screening: LVS 1-5 weeks prior to delivery

diagnosis: culture

treatment: benpen + gen +/-cefotaxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Hearing impairment

A

Bilateral hearing impairment 1/1000

Non syndromic

  • connexin-26 deficiency most common (50% non syndromic)

Syndromic

  • Waardenburg: neural crest syndrome
  • Branchial-oto-renal
  • Pendred: assoc with goitre
  • Usher: assoc retinitis pigmentosa
  • Jervell and Lange-Nielsen: long QT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Hearing loss

Infectious pathogens

A

Congenital: CMV, Rubella, Toxoplasma, Treponema pallidum

Acquired: Borrellia burgdorferi, EBV, Haem influenzae, Lassa virus, Measles, Mumps, Neisseria meningitidis, Enteroviruses, Plasmoadium falciparum, Strep pneumonia, VZV

39
Q

Hearing testing

A

Newborn: auditory brain response

  • summation of AP from 8th CN to midrain

Older infants: behavioural observed audiometry

Toddlers: visual reinforced audiometry

School age: standard pure tone audiometry

Audiograms (dB)

  • mild 20-40, mod 40-60, severe 60-80, profound> 80

Sensorineural: loss at higher frequency

Conductive: loss at lower frequency

40
Q

HIE

A

incidence: 5/1000

Pathophysiology: decreased cerebral perfusion

  • antenatal: impaired maternal oxygenation, impared placental perfusion, fetal haemorrhage
  • intrapartum: placental abruption/prolapse/cord true know, maternal hypotension/fever, foetal OP position
  • post natal: resp distress, CVS disease, anaemia, shock

Secondary insult

  1. Impaired cerebral blood flow, cerebral hypoxia, anaerobic met, increased lactate and death of some neurons
    - hypothermia effective
  2. Delayed neuronal dealth 6 to 100 hrs with neuronal cell apoptosis via accumulation excitory AA (glutamate), opens NMDA channels, influx Ca and cell damage

Outcome: cause of most significant neuronal loss

  • increased iNa/Ca with swelling/edema
  • increased NO/free radicals injury cells

Clinical

  • birth: initial hypotonia/poor resp effort/weak cry
  • hours: LOC, hypotonia, apnoea, bradycardia
  • days: cerebral oedema, brainstem compromise, seizures

Management

  • hypothermia for stage 2/3

Outcome:

  • 20-30% die neonatal period, 25-50% neuro comorbidity

Risk adverse outcome

  • pH25 (72% death), Apgars 0-30 5/20m, decerebrate posturing, absent resps 20mins, abnormal motor 2/52, EEG abnormal 48hrs
41
Q

Hydrops Fetalis

A

2 or more: ascites, pleural effusion, pericardial effusion, oedema, polyhydramnios

Immune vs non-immune

Pathogenesis:

  • Obstructed lymphatic drainage
  • Increased capillary permeability
  • Increased venous pressure
  • Decreased osmotic pressure

Clinical: LGA, decreased fetal movements, maternal preeclampsia/anaemia, preterm labour, birth trauma, PPH

Prognosis: earlier is worse, perinatal mortality 50-98%

42
Q

Hyperinsulinaemia

A

Infant DM mother

  • increasd fetal BGL, hypertrophy B cell, neonatal hyperinsulinaemia
  • resolves 2-4 days

B-W syndrome

  • 50% transient hypoglycaemia due to hyperinsulinaemia

Persistent hyperinsulinaemia hypoglycaemia of infancy

  • gene mutation in ATP dep K channel in beta cell membrane
43
Q

IUGR

A

definition: weight

symmetric: early onset disease, affect celll number eg. chromosomal, malformations, teratogens, infections, HTN

asymmetric: late onset (2nd/3rd tri), decreased weight normal length/HC, preservation carotid blood flow, eg poor nutrition, PET

etiology: 1/3 genetic, 2/3 environmental (40% SGA unknown cause)

  • maternal: malnutrition, hypoxemia, thrombosis, vasculopathys, virus/parasite, substance abuse, toxins, high altitude
  • placental: placental injuries, single umbilical artery, velamentous umbilical cord insertion, placental hemangioma
  • neonatal: karyotype, genetic syndrome, congenital abnormalities, twins
    issues: hypothermia, hypoglycaemia, polycythemia, hyperviscosity, impaire immune function

associations: increased mobidity/mortality

  • increased neonatal death, IHV, NEC, RDS, BPD
  • no association PVL
44
Q

Bronchogenic cyst

A

location: next to midline structures

definition: abnormal budding of tracheal diverticulum

clinical: wheeze, WOB, spontaneous pneumothorax, infection

treatment: always resect

45
Q

Malrotation

A
  • gut straight tube stomach to rectum
  • rotation from week 5
46
Q

Malrotation/Volvulus

A

incidence: 1/5000
associations: 30-60% assoc CDH, omphalocele, gastroschisis, duodenal atresia, meckels, stenosis, hirschsprungs etc
presentation: 50% by 1 month and up to 1 year from volvulus or ladd bands
clinical: bilious vomiting, abdominal pain, distension, tenderness, peritonisis, blood stool
complications: vascular compromise with SMA obstruction and necrosis 6-12hrs, SBS, SBO
investigations: AXR (gasless abdo, duodenal obstruction with double bubble), barium enema (normal 20%, malposition caecum may be seen), upper GI contrast study (displaced duodenum, malposition ligament Treitz on right side abdo, duodenal obstruction with double bubble/bird beak)
management: surgical ladd procedure with reduction volvulus, release lasdd bands and widen base mesentery
outcome: mortality 3-%, recurrent malrotation 2-8%

47
Q

Maternal ITP

A

pathophysiology: IgG from mother can cross placenta and react with fetal plateletes

clinical: symptomatic mother with identifiable platelet Ab should commence on treatment with steroids/IVIG

management: FBC in neonate, rarely platelet transfusion

48
Q

Meconium Aspiration Syndrome

A

Meconium: 10-15% births

MAS: in 5% with meconium

Pathophysiology: meconium aspirated in utero or with 1st breath

  • small airway obstruction causing resp distress
  • may lead to pneumomediastinum/pneumothorax
  • overdistension of chest

Treatment: intubation for suction, supportive, exogenous surfactant, iNO, mechanical ventilation

Outcome: 30% ventilation, 3-5% die, improves within 72 hours

49
Q

Meconium ileus

A

associated CF

cause: absense of pancreatic enzymes with viscous/mucousy meconium
clinical: similar LBO with abdominal distension/vomiting

AXR: mec in colon with proximla dilation

treatment: gastrograffin enema, disempaction, laparotomy

50
Q

Meconium plug

A

definition: firm mass with loss water content

risk factors: small left colon, maternal DM, mothers CF, antenatal Mg, Hirschsprung’s

51
Q

Midgut malrotation

A

Non-rotation:

  • midgut returns to abdomen with no further rotation
  • not as dangerous because base of mesentery still wide
  • foregut in normal position, midgut on right side of abdomen, hindgut on left

Malrotation: (most common type)

  • failure of caecum to move into the right lower quadrant and sits subhepatic
  • duodeno/jejunum remains in position of non-rotation
  • caecum/colon have partial rotation.
  • the mesentery (and the SMA within it) is a narrow stalk which can twist
  • Ladd’s bands from the caecum to the RUQ and can cross/obstruct the duodenum.
52
Q

Milrinone

A

class: bipyridine inodilator

mechanism: cAMP PDE-3 inhibitor

effect: inotropy, CO

use: low CO state

53
Q

MZ Twins

A

0.5% risk

Fertilization of 1 oocyte with division later

  • MCDA division d 4-8
  • MCMA division d 8-12

Monochorionic or Dichorionic

Risks: neurological, mortality, congenital abnormalities

54
Q

Necrotising enterocolitis

A

incidence: 3/1,000 and 6% infants
- only 13% NEC occurs in term infants
onset: usually

preterm risk factors: immature mucosal barrier/permeability/immune system (no IgA at birth), slow gut motility

term risk factors: comorbities (CHD, asphyxia, sepsis, polycythemia, resp)

pathophysiology: ischaemic necrosis intestinal mucosa with inflammation, invasion of gas forming organisms into muscularis and venous system. Mucosal oedema, haemorrhage and transmural necrosis occur. Heals with fibrosis and stenosis.

Feeds: 90% NEC in milk fed infants. Risk decreased with slower increase in feeds, early commencement, human milk and probiotics.

clinical: apnoea, lethargy, poor feeding, temp instability, feed intolerance (distension, tender, PR bleeding, bilious vomiting)

AXR: abnormal gas pattern/dilation, possibly sentinal loop of bowel, pneumotosis intestinalis

bloods: increase lactate/glucose, decrease Na
treatment: supportive (gut rest, NGT aspirated), medical with IV antibiotics(fails 50%), surgical (resection if needed)
complications: sepsis, DIC, strictures
outcome: mortality 20-30%, 50% no long term issues

55
Q

Neonatal Abstinence Syndrome

A

heroine/methadone:

  • most babies withdraw
  • onset
  • tremors and hyperirritability
  • commonly: increased tone/reflexes, fever, tachypnoea, vomiting, diarrhoea, fist sucking
  • less commonly: sneezing, yawning, hiccips, convulsions, apnoeas

alcohol: uncommon

phenobarb: onset 7 days to 2-4 months, same as above

cocaine: withdrawal uncommon

SSRIs:

  • serotonin discontinuation syndrome
  • onset
  • mild symptoms: CNS, motor, resp, GI, temp instability

Treatment:

  • quiet environment, minimal stimulation
  • scores >8 x3, >12 x2
  • morphine, phenobarbitone
  • mortality
56
Q

Neonatal asphyxia

A

definition: acidosis and multiorgan effects

progressive hypoxia/hypercapnia causing:

  1. Acidosis pH<7
  2. Early onset encephalopathy
  3. CP
  4. Exclusion other causes

effect:

CNS: HIE, infarction, ICH, seizures, edema, hypotonia

CVS: ischaemia, poor contractility, tricuspid insuff, hypotension

Pulm: HTN, pulm haemorrhage, RDS

Renal: tubular/cortical necrosis

Adrenal: haemorrhage

GI: performation, ulceration, necrosis

Metabolic: SIADH, hyponatraemia, hypoglycaemia, hypocalcaemia, myoglobinuria

Skin: subcut fat necrosis

Haem: DIC

57
Q

Neonatal CMV

A

incidence: leading cause congenital infection 0.7%

Maternal CMV IgM: 75% false positive due to delayed clearance, reactivation, cross reactivity

Transmission: (greatest infection)

  • primary: 30% transmission (85% asymptomatic, 15% symptomatic)
  • secondary: 1% transmission (99% asymptomatic, 1% symptomatic)

Fetal diagnosis: fetal US/MRI, amniocentesis

Postpartum ix: CMV IgM serology, urine/saliva/blood PCR within 3 weeks

Treatment: antivirals if symptomatic for 6 weeks

Sequelae symptomatic: early mortality 5-10%, microcephaly 35-50%, seizures 10%, chorioretinitis 10-20%, dev delays 70%, SNHL 25-50%

Outcome:

  • more severe if primary in 1st trimester
58
Q

Neonatal fluids

A

TBW: prem 80%, term 75%

ECF: prem 70%, term 45%

Weight loss first week 10-15%: 5% ECF

Sources of water loss:

Kidneys: need 2ml/kg/hr, 2% CO

  • prems: decreased GFR/tubular Na+Bicarb reabsorption/secretion K+H/capacity to concentrate+dilute urine

Skin: evaporation via skin

  • 24 weeks: 200ml/kg/day, term: 20ml/kg/day
  • radiant warmers increase loss by 50%

Respiratory: 50% insensible losses in infant

  • antenatal steroids mature skin/kidneys

Overall:

  • 50% loss skin/resp
  • 50% loss kidneys
59
Q

Neonatal growth

A

Weight: 15g/kg/day

Length: 1cm/week

HC: 0.7cm/week

Nutrition: 100-120kcal/kg/day approx 180ml/kg/day formula

60
Q

Neonatal Hepatitis B

A

Acute infection in pregnancy transmission:

  • 1st 10%
  • 2nd/3rd 75%

Vertical transmission:

  • 90% (HBeAg +ve), 10% (HBeAg -ve)
  • mode of delivery does not alter transmission

Chronic rate:

  • 90% neonates

Of chronic carriers:

  • 25% die to HCC

Treatment:

  • administration IVIg and vaccination

No risk with breastfeeding/vaginal delivery

61
Q

Neonatal hepatitis C

A

Transmission:

  • babies to anti-HCV positive but HCV RNA negative NO RISK
  • 5-10% risk babies born to anti-HCV/RNA positive

Clinical:

  • paediatric HCV infection usually asymptomatic for many years

Follow up: HCV PCR at 2 months, and Anti-HCV antibodies at 18 months

No risk with breast feeding

Needle stick injury 0-5%

Treatment: interferon, interferon-ribavirin

62
Q

Neonatal HIV

A

Low risk MTCT (on HART therapy or commenced on HART and viral load

  • risk of transmission
  • allow vaginal delivery
  • commence on single agent AZT

High risk MTCT:

  • risk of transmission >2%
  • LSCS
  • commenced double agent AZT/ART and PCP prophylaxis

Breast feeding on HART

  • 1-5% risk

Without any intervention (developing country)

  • 20% if bottle fed, 40% breast fed
63
Q

Neonatal HSV

A

Primary HSV:

  • seroconverion >30 weeks (25-50%): administer antivirals w36 to birth
  • seroconversion

Active lesions:

  • deliver via LSCS

Transmission:

  • 85% neonatal HSV acquired perinatally

-

  • 5% postnatally acquired

Risk factors:

  • scalp eletrode/vacuum increases transmission
  • LSCS decreases transmission

Treatment:

asymptomatic high risk/symptomatic:

  • LP, bloods, surface swabs and commence IV aciclovir
  • IV aciclovir improved neurological outcome

asymptomatic low risk

  • monitor for clinical symptoms

Risk of disease:

  • primary genital lesion: 50% infection
  • secondary genital lesion:

Prognosis:

  • infections >70% progress to disseminated disease
  • >70% mortality for disseminated disease
64
Q

Neonatal hypoglycaemia

A

definition: BGL

incidence: transient low BGL 10% newborns

pathogenesis:

  • loss on contunours transport of glucose
  • BGL maintained by hepatic glycogen breakdown immediately after birth
  • stores deplete 8-12 hrs

pathophysiology:

  • Inadequate glucose supply: IUGR
  • impaired glucose utilisation: hyperinsulinaemia, IEM
  • increased glucose utilisation: hyperinsulinaemia, hypotheramia, hepatic dysfunction, anaerobic glycolysis (ischaemia), sepsis, polycythaemia

management:

  • oral feeds
  • IV dextrose
  • glucagon, diazoxide, pancreatectomy

outcome:

  • brain injury, CP, DD, small head circumference
65
Q

Neonatal lupus

A

Neonatal Lupus (maternal SLE)

pathophysiology: IgG antibodies to ENA (anti Ro/SSA or anti-La/SSB) cross placenta between weeks 12-16

incidence: 1% babies develop disease

symptoms: CHB, cutaneous lesions, hepatitis, thrombocytopaenia, neutropaenia

treatment: pacing, heart transplant

66
Q

Neonatal milk

A

Protein: whey dominant

Lipid: 50% caloric intake in milk

Carb: 40% caloric intake, 90% lactose absorbed

Ca/PO4: bone mineralisation

Na: important growth factor, stimulate cell proliferation/protein synthesis

Iron: limited in breast milk

67
Q

Neonatal pulmonary haemorrhage

A

incidence: 10% extreme prems, 75% of patients

risk factors: RDS, PDA, haemorrhagic disease newborn, erythroblastosis foetalis, surfactant, alveolar haemorrhage

cause: haemorrhagic pulmonary oedema with PDA and left to right shunt with high pulmonary flow, of left sided heart failure

CXR: non specific streaky changes

treatment: suction, ET adrenaline, HFOV, surfactant

68
Q

Neonatal seizures

A

Almost all symptomatic to underlygin cause

  • ie. primary epilepsy syndromes are rare

cause:

  • cranial: encephalopathy, haemorrhage, infarct
  • metabolic: hypoglycaemia, hypocalcaemia, hypomagnesia
  • infective
  • chromosomal abnormalities
  • IEM: aminoacidurias, urea cycle defects, organic acidurias
  • drug withdrawal/intoxication
  • neonatal epilepsy syndromes: benign neonatal convulsions, benign neonatal familial convulsions, early myoclonic encephalopathy, early infantile epileptic encephalopathy

outcome:

- early death 35%, neurological impairment 20-60%, DD 55%, post natal epilepsy 20-30%

treatments: phenobarb, phenytoin

69
Q

Neonatal ventilation

A

Goals: oxygenation/ventilation

Oxygenation: FiO2 and MAP

Ventilation: TV and RR

Permissive hypercapnia

  • pH 7.25-7.35, pCO2 40-60mmHg, BE 0 to -4

Settings: RR 60, Ti 0.35 secs

Types:

  • IPPV
  • SIMV: synchronised intermittent mandatory ventilation
  • SIPPV: synchronised intermittent positive airway pressure vent
  • PSV: pressure support ventilation
70
Q

Nitric Oxide PPHN

A

Definition: selective pulmonary vasodilator

Indications: PPHN >34wks, CDH

Mechanism: binds guanylate cyclase increasing cGMP and vasodilation

  • vasodilates well ventilated regions reducing VQ mismatch

Toxicity: binds Hb to form methaemaglobin systemically, may cause pulmonary injury/thrombocytopaenia

Sildenafil (PDE5 inhibitor) can be used in longer term management

71
Q

Noradrenaline

A

class: catecholamine

mechanism: alpha>beta

effect: similiar to adrenaline but less vasodilation (beta 2)

use: septic shock, vasodilation

72
Q

Osteopaenia of prematurity

A

risk factors: prem/LBW, TPN>4weeks, BPD, long term steroids, NEC

clinical: onset 3-12 weeks, decreased Ph/Ca, increased ALP, fractures

diagnosis: XR

management: calcium, phosphate supplementation

73
Q

Outcomes IUGR

A

Growth:

  • catch up 6-12 months
  • severe SGA (15%) shorter throughout life

Neurodevelopmental:

  • risk of neurodev/cognitive issues
  • poorer school performance
  • attention issues in girls

Physical:

  • increased IHD, HTN, stroke, DM, hypercholesterolaemia
74
Q

Parenteral nutrition

A

Target 100kcal/kg/day to gain 15g/kg/day

Lipid 30% energy PN: 1-2g/kg/day=1kcal/ml

Carb (dextrose) 60% energy PN: 3.4kcal/ml

Protein 10% energy PN: 2-3g/kg/day=4kcal/g

Na: 2-3mmol/kg/day

Ca: 1-2mmol/kg/day

IRON NOT PART TPN

Needs selenium if PN>2 months

75
Q

Perinatal stroke

A

incidence: 1/4000

defintion: CVA weeks 20 weeks gestation to 28 days postnatally

clinical: seizures, lethargy, hypotonia, feeding difficulties, apnea

risk factors:

maternal RF: cocaine, prothrombotic disorders

placental RF: PET, chorioamnionitis, vasculopathy

newborn RF: prothrombotic disorders, CHD, meningitis, systemic infection

types:

1. Arterial ischaemic: abnormal coagulation 1/2 cases.

  • seizures, encephalopathy, unilateral hemiparesis, exaggerated reflexes
  • normal development 20-33%, motor disability common

2. Cerebral sinovenous thrombosis

  • venous infarct, placental lesions, involve supeficial veins (superior saggital sinus/lateral sinuses)
  • >95% survive neonatal period, 20% mortality, 60% deficits, 20% normal

3. Haemorrhagic

  • haemorrhagic conversion of ischaemic infart OR
  • primary intraparenchymal haem from vascular abnormalities
  • periventricular haemorrhagic infarction 15-20% IVH
  • neonatal alloimmune thrombocytopenia
76
Q

Posterior urethral valves

A

incidence: 1:8000 males

definition: obstructive membrane in posterior male urethra secondary to abnormal development

diagnosis: ultrasound, VCUG

side effects: renal and resp failure (low AF)

treatment: endoscopic valve ablation

77
Q

PPHN

A

Hypoxic baby normal CXR

78
Q

Pregnancy Drug Categories

A

Category A = no risk shown in human studies

Categpry B = no risk shown in animal studies OR some risk in animal studies but not confirmed on human studies

Category C = either definite risk in animal studies OR no data in human or animal studies

Category D = some risk (but the benefit may exceed the risk e.g. in life threatening circumstances)

Category X = contraindicated in pregnancy

79
Q

Premature physiology

A

Fluid requirement: 2-3ml/kg/hr insensible losses due to immature skin, lack of subcut tissue, large SA

Drugs: immature renal clearance dependent gestation/age

Renal: poor urine concentrating (7.5-30mOsm/kg/day)

Nutrition: deficit folate (decrease 1st week then low 2-3m), vitamin D, Vit A

80
Q

Prematurity prognosis

A

Survival

  • 23: 15%
  • 24: 56%
  • 25: 80%
  • 500-600g: 20%
  • 1250-1500: 90%
  • 1500-2500: 95%

Positive predictors: antenatal steroids, female, singleton

Long term associations: T2DM, obesity, CVD (HTN, IHD)

81
Q

IVH and periventricular leukomalacia

A

timing5 days (50% day 1, 75% first 3 days)

cause: spontaneous (prems), less commonly haem disturbances, vasc malformations, trauma, vit K deficiency

risk factors: prem, RDS, pneumothorax, HIE, hypotension, reperfusion injury, thrombocytopenia, hypervolemia, HTN, PDA

etiology: 30% prems

pathogenesis: occurs subependymal germinal matrix: site origin embryonal neurons and foetal glial cells that migrate to cortex and blood vessels are immature

  • PVL occurs after grade IV IVH due to venous congestion: periventricular haemorrhage/necrosis with focal necrotic lesions and diffuse white matter changes (assoc CP as impacts corticospinal tracts)

grading:

grade 1 (35%): subependymal only or

grade 2 (40%): bleeding in ventricle without dilation (10-50% ventricle)

grade 3: IVH with ventricular dilation (>50% ventricle)

grade 4: IV and parenchymal

clinical: 25-50% no sx, impaired neuro, PVL silent until CP in infancy

prevention: antenatal steroids

management: surveillance, shunt

82
Q

RDS

A

Incidence:

Risks: prematurity, GDM, twins, LSCS, Precipitous delivery, maternal hx, asphyxia, male/white

Protective: steroids, maternal HTN

Pathophysiology:

  • insufficient surfactant (mature levels 35wks)
  • high surface tension: atelectasis/poor gas exchange with VQ mismatch
  • atelectasis, hyaline membrane formation, edema

Clinical: onset resp distress in minutes, fine rales, peak at 3 days

CXR: fine reticular markings with air bronchograms

Treatment: steroids, surfactant first few hours (improved survival, decreased air leak/BPD)

83
Q

Retinopathy of prematurity

A

definition: developmental vascular proliferative disorder

  • most common cause of cortical blindness

risk factors: prematurity (

pathophysiology:

  • retinal vascularisation weeks 15 to 36 (ongoing in prems)
  • initial injury due to hypotension/hypoxia/hyperoxia causing them to grow abnormally with increasd permabilit causing oedema/haemorrhage
  • vasc endothelial growth factor/IGF-1 involved

classification

  • stage 1: flat white lin demarcate vasc/avasc retina
  • stage 2: fibrous ridge into vitreous
  • stage 3: new blood vessels and fibrous tissue in a ridge into vitreous
  • stage 4: partial retinal detachment
  • stage 5: total retinal detachment

prognosis

  • stage 1/2: usually regress but surveillance until vascularisation complete
  • stage 3: usually regresses, may need tx, assoc refractory errors/squint
  • stage 4/5: retinal detatchment, poor visual prognosis
84
Q

Rh/ABO incompatibility

(erythroblastosis foetalis)

A

cause: destruction fetal RBC by maternal IgG

  • Ab produced when fetus produce Ag not expressed by mother

types:

Rh haemolytic disease (most common alloimmune HDN)

  • 90% D Ag, 10% C or E Ag
  • prenatally, abortion, delivery
  • Rh+ blood from fetus into mother and mother develops IgM then IgG anti-D (IgG crosses placenta to cause disease)
  • when also ABO incompatible Rh+ cells removed by existing Anti-A Anti-B IgM causing less severe disease

ABO incompatibility (less severe)

  • some mothers naturally anti-A/anti-B IgG from nature
  • disease can occur in 1st pregnancy
  • 15% all pregnancies, only HDN 4%
  • increased SBR at 24hrs
    • Coombs, ABO incompatibility, spherocytes
  • may need pRBC at weeks due to slow haemolytic disease

Diagnosis: decreased Hb, increased retic, polychromasia

  • Kleihauer test: determine fetal Hb in maternal blood (fetal Hb acid resistant)
  • Coombs test: presence of maternal Ab on neonatal RBC

Treatment: Anti-D antenatally/delivery, transfusions, exchange transfusions, IVIG

85
Q

Talipes equinovarus

A

incidence: 1/1000, mostly bilateral

pathogenesis: hypoplastic tarsals/talus with secondary generalised limb hypoplasia

causes

  • congenital (75%)
  • teratologic: NMDs (myelomeningocele, arthrogyrposis)
  • positional: in utero deformity

clinical: hindfoot equinus/varus, foreffot adduction

treatment: Ponseti method with serial casting, tendon transfer 20%

86
Q

Teratogens

A

cause 10% of all anomalies

1st trimester: more likely to cause problems/MC

Major teratogens:

ACEi: trimester 2/3 renal abnormalities

aminoglycosides: damage to kidney

EtOH: FAS, IUGR, behaviour/cognitive

lithium: Ebstein anomaly, macrosomia

MTX: IUGR, hypotonia, congenital anomalies, DD

NSAIDs: closure DA in third trimester

phenytoin: craniofacial, nail, cardiac, IUGR, neuroblastoma, bleeding

prednisone: oral clefts

smoking: IUGR, facial clefts

sodium valproate: NTDs, facial, cardiac, limb, hypospadias

trimethoprim: teeth problems trimesters 2/3

vitamin D: supravalvular aortic stenosis, hypercalcaemia

warfarin: embyopathy weeks 6-9, cartilage defects (esp nasal)

87
Q

Therapeutic hypothermia

A

Indication: stage 2/3 encephalopathy

Mechanism: downregulates secondary mediators of injury with decreased apoptosis/glutamate/free radicals/NOP/lactate and oedema

Contraindications:

Method: 6hrs, target 32-34 degrees, 48-72hrs, rewarm slowly 0.5 degrre/hr max, continuous rectal probe

Side effects: bradycardia, hypotension, PPHN, coagulopathy, hypoglycaemia, hypokalaemia, pulmonary edema, sepsis

Outcome: death 46% if cooled, 60% without

88
Q

Transcobalamin II deficiency

A

incidence: autosomal recessive

pathophysiology: TC-II principle transport vehicle of B12

investigations: serum B12 normal

clinical: FTT, diarrhoea, vomiting, glossitis, neurological abnormalities in 1st week of life

treatment: large dose parenteral vitamin B12

89
Q

TTN

A

Preterm or term/VD or LSCS

Pathophysiology:

  • retained fluid from foetal circulation
  • decreased pulmonary compliance
  • increased dead space

Clinical: early onset resp distress, chest clear

CXR: fluid in fissures, vasc markings, flat diaphragms

Treatment: usually FiO2

90
Q

TTTS

A

vascular connections all MC twins

TTTS 10-15% MZ

  • trigger hypovolaemia in donor twin, causing vasoactive peptides, HTN and shunting to recipient

Donor: oligohydramnios

Recipient: polyhydramnios, HTN, hydrops fetalis

Management: US, amnioreduction in recipient, laser ablation, selective foetal reduction

91
Q

Twin Anaemia Polycythaemia Sequence

A

atypical form TTTS

discrepant Hb concentrations WITHOUT poly/oligohydramnios

donor twin: low MCA velocity

recipient twin: high MCA velocity

92
Q

Types hearing loss

A

Conductive: most is acquired

  • anomalies pinna, external auditory canal, TM, ossicles, congenital cholesteatoma, TM perforation, ossicular discontinuity, tympanosclerosis, acquired cholesteatoma, masses middle ear, salivary gland tumours

Sensorineural: congenital or acquired

  • genetic, infectious, autoimmune, anatomic, traumatic, ototoxic
93
Q

Vasopressin

A

class: endogenous peptide

mechanism: V1R, V2R, V3R, OTR receptors

effect: antidiuresis, SVR/PVR, platelet aggregation

use: septic shock

94
Q

Vitamin K deficiency bleeding

A

Early (0-24 hours)

  • site: cephalo, subgaleal, ICH, GI, umbilical, intaabdominal
  • risks: maternal drugs (phenobarb, phenytoin, warfarin, rifampicin, isoniazid)
  • prevention: antenatal maternal vit K
  • incidence: rare

Classic (2-7 days)

  • site: GI, ENT, ICH, cutaneous, circumcision, injection site
  • risks: vit K deficiency, BF
  • prevention: IM Vit K birth
  • incidence: 2% if no vitamin K

Late (1-6 months)

  • site: ICH, GI, cutaneous, ENT, injection sites, thoracic
  • risks: Vit K malabsorption, CF, cholestasis, biliary atresia, BF
  • prevention: parental/oral Vit K